教育中心 >> 预读材料
-
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESJOURNAL：JACC: Cardiovascular Interventions
-
Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting StentsJOURNAL：
-
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus StatementJOURNAL： JACC Cardiovasc Interv and Catheter Cardiovasc In
-
Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main DiseaseJOURNAL：J Am Coll Cardiol.
-
Characterization of lesions undergoing ischemia-driven revascularization after complete revascularization versus culprit lesion only in patients with STEMI and multivessel disease - A DANAMI-3-PRIMULTI substudyJOURNAL：EuroIntervention.
-
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upJOURNAL：Circulation.
-
Long-term Survival following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-On Study)JOURNAL：J Am Coll Cardiol.
-
Impact of different final optimization techniques on long-term clinical outcomes of left main cross-over stentingJOURNAL：Cardiovasc Revasc Med.
-
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trialJOURNAL：EuroIntervention.
-
Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL TrialJOURNAL：JACC Cardiovasc Interv.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
